Evidence map›Paper›PMID 36235563›Full record

ArticleNutrients2022

Improved Macro- and Micronutrient Supply for Favorable Growth and Metabolomic Profile with Standardized Parenteral Nutrition Solutions for Very Preterm Infants.

Alida Kindt, Yvonne Kraus, Livia Dahlia Rasp, Kai M Foerster, Narges Ahmidi, Andreas W Flemmer, Susanne Herber-Jonat, Florian Heinen, Heike Weigand, Thomas Hankemeier and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Alida KindtInstitute of Computational Biology, Helmholtz Zentrum München, 85764 Oberschleißheim, Germany.ORCID 0000-0001-6551-6030
Yvonne KrausCenter for Comprehensive Developmental Care (CDeCLMU), Division of Pediatric Neurology, Developmental Medicine and Social Pediatrics, Department of Pediatrics, Dr von Hauner Children's Hospital, Munich University Hospital, Ludwig Maximilians University, 80336 Munich, Germany.
Livia Dahlia RaspMetabolomics and Analytics Center, Leiden Academic Centre for Drug Research, Leiden University, 2333 AL Leiden, The Netherlands.ORCID 0000-0003-0164-2163
Kai M FoersterComprehensive Pneumology Center, Helmholtz Zentrum München, Member of the German Lung Research Center (DZL), 81377 Munich, Germany.
Narges AhmidiInstitute of Computational Biology, Helmholtz Zentrum München, 85764 Oberschleißheim, Germany.ORCID 0000-0003-0983-9964
Andreas W FlemmerDepartment of Neonatology, Perinatal Center, Dr. von Hauner Children's Hospital, Ludwig-Maximilians University, 80337 Munich, Germany.
Susanne Herber-JonatDepartment of Neonatology, Perinatal Center, Dr. von Hauner Children's Hospital, Ludwig-Maximilians University, 80337 Munich, Germany.
Florian HeinenCenter for Comprehensive Developmental Care (CDeCLMU), Division of Pediatric Neurology, Developmental Medicine and Social Pediatrics, Department of Pediatrics, Dr von Hauner Children's Hospital, Munich University Hospital, Ludwig Maximilians University, 80336 Munich, Germany.ORCID 0000-0002-3872-6136
Heike WeigandCenter for Comprehensive Developmental Care (CDeCLMU), Division of Pediatric Neurology, Developmental Medicine and Social Pediatrics, Department of Pediatrics, Dr von Hauner Children's Hospital, Munich University Hospital, Ludwig Maximilians University, 80336 Munich, Germany.
Thomas HankemeierMetabolomics and Analytics Center, Leiden Academic Centre for Drug Research, Leiden University, 2333 AL Leiden, The Netherlands.ORCID 0000-0001-7871-2073
Berthold KoletzkoDivision of Metabolic and Nutritional Medicine, Department of Paediatrics, Dr. von Hauner Children's Hospital University Hospital, Ludwig-Maximilians University, 81377 Munich, Germany.ORCID 0000-0002-5345-7165
Jan KrumsiekInstitute of Computational Biology, Helmholtz Zentrum München, 85764 Oberschleißheim, Germany.
Juergen BablPharmacy of the University Hospital, Ludwig-Maximilians University, 81377 Munich, Germany.
Anne HilgendorffCenter for Comprehensive Developmental Care (CDeCLMU), Division of Pediatric Neurology, Developmental Medicine and Social Pediatrics, Department of Pediatrics, Dr von Hauner Children's Hospital, Munich University Hospital, Ludwig Maximilians University, 80336 Munich, Germany.
Ludwig-Maximilians-Universität München · DEHelmholtz Zentrum München · DELeiden University · NLCornell University · US

Funding

Helmholtz Association NWG VH-NG-829
6 · The paper itself

Abstract

Very preterm infants are at high risk for suboptimal nutrition in the first weeks of life leading to insufficient weight gain and complications arising from metabolic imbalances such as insufficient bone mineral accretion. We investigated the use of a novel set of standardized parenteral nutrition (PN; MUC PREPARE) solutions regarding improving nutritional intake, accelerating termination of parenteral feeding, and positively affecting growth in comparison to individually prescribed and compounded PN solutions. We studied the effect of MUC PREPARE on macro- and micronutrient intake, metabolism, and growth in 58 very preterm infants and compared results to a historic reference group of 58 very preterm infants matched for clinical characteristics. Infants receiving MUC PREPARE demonstrated improved macro- and micronutrient intake resulting in balanced electrolyte levels and stable metabolomic profiles. Subsequently, improved energy supply was associated with up to 1.5 weeks earlier termination of parenteral feeding, while simultaneously reaching up to 1.9 times higher weight gain at day 28 in extremely immature infants (<27 GA weeks) as well as overall improved growth at 2 years of age for all infants. The use of the new standardized PN solution MUC PREPARE improved nutritional supply and short- and long-term growth and reduced PN duration in very preterm infants and is considered a superior therapeutic strategy.

Indexed as

Infant, Premature, DiseasesParenteral Nutrition SolutionsElectrolytesFemaleFetal Growth RetardationHumansInfantInfant, NewbornInfant, PrematureMicronutrientsWeight GainElectrolytesMicronutrientsParenteral Nutrition Solutionselectrolytesgrowthmacronutrientsmicronutrientsparenteral nutritionpreterm

Identifiers

PMID36235563
PMCPMC9572167
OpenAlexW4296614833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.